Risk of hypoglycaemia associated with second-line agents in routine care patients with type 2 diabetes treated with metformin

被引：0
|
作者：
Pawar, A. [1 ]
Patorno, E. [1 ]
Lee, H. [1 ]
Munshi, M. [2 ]
Kim, D. [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
846
引用
收藏
页码：S411 / S411
页数：1
相关论文
共 50 条
  • [1] Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study
    Chang, Y. -C.
    Chuang, L. -M.
    Lin, J. -W.
    Chen, S. -T.
    Lai, M. -S.
    Chang, C. -H.
    DIABETIC MEDICINE, 2015, 32 (11) : 1460 - 1469
  • [2] PATIENTS' PREFERENCES FOR NEWER SECOND-LINE PHARMACOLOGICAL AGENTS IN TYPE 2 DIABETES
    Banjara, B.
    Poudel, N.
    Garza, K. B.
    Westrick, S. C.
    Whitley, H. P.
    Ngorsuraches, S.
    VALUE IN HEALTH, 2022, 25 (07) : S566 - S566
  • [3] Choosing a second-line therapy after metformin in type 2 diabetes mellitus
    Carol Wilson
    Nature Reviews Endocrinology, 2012, 8 (8) : 441 - 441
  • [4] Second-Line Agents for the Treatment of Type 2 Diabetes and Prevention of CKD
    Yu, Margaret K.
    Kim, Sun H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (12): : 2104 - 2106
  • [5] Second-Line Pharmaceutical Treatments for Patients with Type 2 Diabetes
    Vashisht, Rohit
    Patel, Ayan
    Dahm, Lisa
    Han, Cora
    Medders, Kathryn E.
    Mowers, Robert
    Byington, Carrie L.
    Koliwad, Suneil K.
    Butte, Atul J.
    JAMA NETWORK OPEN, 2023, 6 (10) : E2336613
  • [6] Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes
    Holstein, A
    Egberts, EH
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2003, 111 (07) : 405 - 414
  • [7] Second-line Therapy for Type 2 Diabetes
    Krome, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (19) : 1127 - 1128
  • [8] Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France
    Vexiau, P.
    Mavros, P.
    Krishnarajah, G.
    Lyu, R.
    Yin, D.
    DIABETES OBESITY & METABOLISM, 2008, 10 : 16 - 24
  • [9] RISK OF INCIDENT GOUT ASSOCIATED WITH INITIATION OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS VERSUS OTHER SECOND-LINE AGENTS AMONG METFORMIN USERS WITH TYPE 2 DIABETES
    Yokose, C.
    Mccormick, N.
    Lu, L.
    Wei, J.
    Zhang, Y.
    Choi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 171 - 171
  • [10] Risk of Incident Gout Associated with Initiation of Sodium-glucose cotransporter-2 Inhibitors versus Other Second-line Agents Among Metformin Users with Type 2 Diabetes
    McCormick, Natalie
    Yokose, Chio
    Lu, Na
    Choi, Hyon K.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1480 - 1482
12345